Celltrion Pharm068760
Celltrion Pharm (068760) Preliminary Earnings, Nov 9, 2026
Filing date ·
Celltrion Pharm reported preliminary Q3 2026 results (separate): Revenue of KRW 161.9 billion (+17.1% year over year), operating profit of KRW 23.9 billion (+4…
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.